In this study, the role of nitric oxide (NO) in the modulation of the activity of NCX1, NCX2, and NCX3 exchangers was investigated in baby hamster kidney cells singly transfected with each of these isoforms by single-cell Fura-2-microfluorometry and patch clamp. Furthermore, the molecular determinants of NO on each isoform were identified by deletion, site-directed mutagenesis, and chimera strategies. Our data revealed four main findings. First, the NO-donor S-nitroso-N-acetylpenicillamine (SNAP; 10 nM) and the NO-precursor L-arginine (10 mM) were both able to increase NCX1 activity in a cGMP-independent way. Moreover, within the amino acid sequence 723 to 734 of the f-loop, Cys730 resulted as the target of NO on NCX1. Second, SNAP and L-arginine were able to increase NCX2 activity, but this effect was prevented by the guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). In addition, the membrane-permeable 8-bromoguanosine-cGMP alone was able to mimic the stimulatory effect of the gaseous mediator, suggesting the involvement of a cGMP-dependent mechanism. Within the amino acid sequence 699 to 744 of the f-loop, Ser713 was the NO molecular determinant on the NCX2 protein; Third, NCX3 activity was instead down-regulated by NO in a cGMP-independent manner.
Introduction
Ca 2ϩ ions play a crucial role in controlling a large number of cellular processes, including migration, proliferation, apoptosis, neurotransmitter release, and neuronal synaptic plasticity (Berridge et al., 2000) . Complex patterns regulate the specificity of Ca 2ϩ signaling through the activity of plasma membrane channels and transporters, including the Na ϩ /Ca 2ϩ exchanger (NCX). For instance, this bidirectional high-capacity and low-affinity ionic transporter, by exchanging three Na ϩ ions for one Ca 2ϩ ion (Sanchez-Armass and Blaustein, 1987; Annunziato et al., 2004) , plays a relevant role in maintaining intracellular free Ca 2ϩ homeostasis. Three different gene products of NCX have been cloned (Nicoll et al., 1990 (Nicoll et al., , 1996 Li et al., 1994) : NCX1, which is the only isoform expressed in the heart and is ubiquitously expressed in several tissues, and NCX2 and NCX3, which are widely expressed in the brain (Papa et al., 2003) and in the skeletal muscle (Lee et al., 1994) . Recent evidence has shown that the three NCX isoforms play a differential role in several neurodegenerative diseases, such as brain ischemia Boscia et al., 2006; Secondo et al., 2007; Molinaro et al., 2008; Sirabella et al., 2009 ), Alzheimer's disease (Wu et al., 1997; Peers et al., 2004) , and multiple sclerosis (Inglese et al., 2010) , by contributing to the maintenance of ionic homeostasis and cell survival (Secondo et al., 2007; Sirabella et al., 2009) .
It is noteworthy that several intracellular and extracellular transduction mechanisms such as Na ϩ and Ca
2ϩ
, intracellular pH values, Akt/protein kinase B, protein kinase A, protein kinase C, and reactive oxygen species, which are all involved in the pathophysiology of neurodegenerative diseases, also function as regulatory factors of the Na ϩ /Ca 2ϩ exchanger activity Formisano et al., 2008) . Among these transductional mechanisms, nitric oxide (NO) has been suggested as a possible candidate for the regulation of NCX activity (Furukawa et al., 1991; Asano et al., 1995; Nagano et al., 2004) . On the other hand, it has already been demonstrated that NO can regulate numerous classes of ion channels and iontransporting mechanisms involved in the maintenance of intracellular Na ϩ and Ca 2ϩ homeostasis in the central nervous system. In particular, NO can interact with the sodium-potassium pump (Na ϩ /K ϩ ATPase); with plasma membrane channels, including voltage-dependent calcium channels, voltage-dependent tetrodotoxin-sensitive Na ϩ , ether-a-go-go-related K ϩ (Taglialatela et al., 1999; Secondo et al., 2006) and voltage-dependent at big-and small-conductance Ca 2ϩ -dependent K ϩ channels (Brakemeier et al., 2003) ; and, finally, with intracellular ligand-gated calcium channels, such as inositol trisphosphate-and ryanodinesensitive channels (Annunziato et al., 2002) . In all of these cases, NO acts by either activating or inhibiting these ioniccontrolling mechanisms (Taglialatela et al., 2001; Annunziato et al., 2002; Francis et al., 2010) .
Considering the relevant role played by the NCX isoforms and NO in the maintenance of ionic homeostasis and in the regulation of several cellular functions under physiological and pathophysiological conditions, the aims of the present study were 1) to characterize the effect of NO on the activity of each NCX isoform in BHK cells stably transfected with NCX1, NCX2, and NCX3 by means of Fura-2 microfluorometry and patch clamp, 2) to investigate the transductional mechanisms underlying NO-mediated effects on NCX isoforms, and 3) to identify, by means of deletion and sitedirected mutagenesis and the generation of chimeric Na ϩ / Ca 2ϩ exchangers, the molecular determinants of NO on each of the three isoforms.
Materials and Methods
Cell Culture. BHK cells stably transfected with canine cardiac NCX1, rat brain NCX2, or NCX3 were grown on plastic dishes in a mix of Dulbecco's modified Eagle's medium and Ham's F12 media (1:1; Invitrogen, San Giuliano Milanese, Italy) supplemented with 5% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin (Sigma-Aldrich, St. Louis, MO). Cells were cultured in a humidified 5% CO 2 atmosphere; the culture medium was changed every 2 days. For microfluorometric and electrophysiological studies, cells were plated on glass coverslips (Thermo Fisher Scientific, Waltham, MA) coated with poly(L-lysine) (30 g/ml; Sigma-Aldrich) and used at least 12 h after seeding.
Generation and Stable Expression of Wild-Type, Mutant, and Chimeric Na ؉ /Ca 2؉ Exchangers. Dog heart NCX1.1, rat brain NCX2.1, and NCX3.3 cDNAs, all generous gifts from Dr. Kenneth Philipson (University of California, Los Angeles, Los Angeles, CA), were cloned into pcDNA3.1 expression vector. NCX1, NCX2, and NCX3 mutants were generated by means of QuikChange sitedirected mutagenesis kit (Stratagene, La Jolla, CA). The amino acid regions 246 to 680, 269 to 662, and 292 to 708 were deleted from NCX1, NCX2, and NCX3, respectively. All other mutants of NCX1, NCX2, and NCX3 were obtained as described above. Successful construction of the modified cDNAs was verified by sequencing (Primm, Milan, Italy) . Wild-type, mutant, and chimeric exchangers were stably transfected in the BHK cell line by Lipofectamine 2000 (Invitrogen, Carlsbad, CA) protocol. Stable cell lines were selected by G418 resistance and by a Ca 2ϩ -killing procedure (Iwamoto et al., 1998) . Nitric Oxide Detection with 4,5-Diaminofluorescein-2-diacetate Assay. Cells were loaded with 10 M 4,5-diaminofluorescein-2-diacetate (DAF-2DA) in a humidified 5% CO 2 atmosphere at 37°C for 20 min in Normal Krebs' solution (5.5 mM KCl, 160 mM NaCl, 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES-NaOH, pH 7.4) containing the drugs or their vehicles, as described previously (Melisi et al., 2006) . Thereafter, fluorescent cells were fixed with 4% (w/v) paraformaldehyde in phosphate-buffered saline for 5 min at 4°C. This procedure permits a subsequent densitometric analysis with the fluorescence microscope Nikon Eclipse E400 (Nikon, Torrance, CA) set at an excitation/emission wavelength of 495/515 nm. Fluorescent images were then stored and analyzed with Pro-Plus software (Media Cybernetics, Silver Spring, MD). Data were calculated as the percentage of sample fluorescence compared with that of controls.
[Ca 2؉ ] i Measurement. [Ca 2ϩ ] i was measured by single-cell computer-assisted videoimaging. In brief, BHK cells were loaded with 10 M Fura-2 acetoxymethyl ester (Fura-2/AM) for 30 min at 37°C in normal Krebs' solution containing the following: 5.5 mM KCl, 160 mM NaCl, 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES-NaOH, pH 7.4. At the end of the Fura-2/AM loading period, the coverslips were placed into a perfusion chamber (Medical System, Co. Greenvale, NY) mounted onto the stage of an inverted Zeiss Axiovert 200 microscope (Carl Zeiss GmbH, Jena, Germany) equipped with a FLUAR 40ϫ oil objective lens. The experiments were carried out with a digital imaging system consisting of a MicroMax 512BFT cooled charge-coupled device camera (Princeton Instruments, Trenton, NJ), a LAMBDA 10-2 filter wheeler (Sutter Instrument Company, Novato, CA), and a Meta-Morph/MetaFluor Imaging System software (Molecular Devices, Sunnyvale, CA). After loading, cells were alternatively illuminated at wavelengths of 340 and 380 nm by a xenon lamp. The emitted light was passed through a 512-nm barrier filter. Fura-2 fluorescence intensity was measured every 3 s. Forty to sixty-five individual cells were selected and monitored simultaneously from each coverslip. All of the results were presented as cytosolic Ca 2ϩ concentrations. Assuming that the K D for FURA-2 was 224 nM, the equation of Grynkiewicz et al. (1985) was used for calibration. NCX activity was evaluated as Ca 2ϩ uptake through the reverse mode by switching the normal Krebs' medium to Na ϩ -deficient NMDG ϩ medium (Na ϩ -free): 5.5 mM KCl, 147 mM N-methyl glucamine, 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES, pH 7.4. These experiments were performed in the presence of the irreversible and selective inhibitor of the sarco-(endo)plasmic reticulum Ca 2ϩ ATPase thapsigargin (1 M), as described previously (Secondo et al., 2007) .
Electrophysiology. I NCX was recorded by the patch-clamp technique in whole-cell configuration, as reported previously . Currents were filtered at 5 kHz and digitized using a Digidata 1322A interface (Molecular Devices). Data were acquired and analyzed using the pClamp software (version 9.0; Molecular Devices). The I NCX was recorded starting from a holding potential of Ϫ60 mV to a short-step depolarization at ϩ60 mV (60 ms) (He et al., 2003) . Then, a descending voltage ramp from ϩ60 to Ϫ120 mV was applied. The current recorded in the descending portion of the ramp (from ϩ60 to Ϫ120 mV) was used to plot the current-voltage (I-V) relation curve. The magnitudes of I NCX were measured at the end of ϩ60 mV (reverse mode) or ϩ10 mV (only for NCX1) and at the end of Ϫ120 mV (forward mode), respectively. Because Ni 2ϩ blocks I NCX , NiCl 2 (5 mM) was routinely added to measure the NCX-independent Nitric Oxide Differently Modulates NCX Isoforms 559 at ASPET Journals on July 7, 2017 molpharm.aspetjournals.org currents. The Ni 2ϩ -insensitive components were subtracted from total currents to isolate I NCX . Cells were perfused with external Ringer solution containing 126 mM NaCl, 1.2 mM NaHPO 4 , 2.4 mM KCl, 2.4 mM CaCl 2 , 1.2 mM MgCl 2 , 10 mM glucose, and 18 mM NaHCO 3 , pH 7.4. Tetraethylammonium (TEA; 20 mM), 50 nM tetrodotoxin, and 10 M nimodipine were added to the Ringer's solution to block TEA-sensitive K ϩ , tetrodotoxin-sensitive Na ϩ , and L-type Ca 2ϩ currents. The dialyzing pipette solution contained 100 mM potassium gluconate, 10 mM TEA, 20 mM NaCl, 1 mM magnesium ATP, 0.1 mM CaCl 2 , 2 mM MgCl 2 , 0.75 mM EGTA, and 10 mM HEPES, adjusted to pH 7.2 with Cs(OH) 2 . Possible changes in cell size occurring upon specific treatments were calculated by monitoring the capacitance of each cell membrane, which is directly related to membrane surface area, and by expressing the current amplitude data as current densities (measured in picoamperes per picofarad). Capacitive currents were estimated from the decay of capacitive transients induced by 5-mV depolarizing pulses from a holding potential of Ϫ80 mV and acquired at a sampling rate of 50 kHz. The membrane capacitance was calculated according to the following equation: C m ϭ c ⅐ I o /⌬E m (1 Ϫ I ϱ /I o ), where C m is membrane capacitance, c is the time constant of the membrane capacitance, I o is the maximum capacitive current value, ⌬E m is the amplitude of the voltage step, and I ϱ is the amplitude of the steady-state current.
Western Blot Analysis. Stably transfected BHK cells were lysed with a buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 10 mM NaF, and a protease inhibitor cocktail (0.1% aprotinin, 1 g/ml leupeptin, 0.7 mg/ml pepstatin) (Roche Diagnostics, Monza, Italy). After centrifugation at 13.400 rpm at 4°C for 20 min, the supernatants were collected. Protein concentration was estimated using the Bradford reagent (Bio-Rad Laboratories, Segrate, Milan, Italy). Then, 100 g of protein was mixed with a Laemmli sample buffer. The samples were separated on 8% SDS-polyacrylamide gel electrophoresis and transferred onto Amersham Hybond-ECL nitrocellulose membranes (GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK). The nonspecific binding sites were blocked by incubation in 5% nonfat dry milk in Tris-buffered saline/0.1% Tween 20 (Sigma-Aldrich) for 1 h at room temperature. Membranes were then incubated overnight at 4°C in the blocking buffer with polyclonal anti-neuronal nitric-oxide synthase (nNOS) (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA), anti-endothelial nitric-oxide synthase (eNOS) (1:1000; Santa Cruz Biotechnology), and monoclonal anti-␤-actin (1:1000; Sigma-Aldrich). Membranes were washed with Trisbuffered saline/0.1% Tween 20 and incubated with the horseradish peroxidase-conjugated secondary antibodies (1:2000; GE Healthcare) for 1 h at room temperature in 5% nonfat dry milk. Immunoreactive bands were detected with the enhanced chemiluminescence reagent (GE Healthcare).
Statistical Analysis. All data were expressed as mean Ϯ S.E.M. Statistical comparisons between treated experimental groups and controls were performed using the one-way analysis of variance, followed by the Newman-Keuls test. P Ͻ 0.05 was considered statistically significant.
Results
Pharmacological Regulation of DAF-2DA-Monitored NO Level in Stably Transfected BHK-NCX1, BHK-NCX2, and BHK-NCX3 Cells. Western blot analysis revealed that BHK wild-type (BHK-Wt) and BHK cells stably transfected with each of the NCX isoforms expressed eNOS, whereas the splicing variants of nNOS were not detected (Fig. 1A) . In these cells, when the NOS substrate L-arginine at ASPET Journals on July 7, 2017 molpharm.aspetjournals.org Downloaded from (10 mM) was administered, an increase in DAF-2-monitored NO level was detected intracellularly (Fig. 1B) . Likewise, the addition of the NO donor SNAP (10 nM) significantly increased intracellular DAF-2 fluorescence compared with respective untreated controls (Fig. 1B) . Identical results were obtained in BHK-Wt exposed to L-arginine (10 mM) or SNAP (10 nM) (data not shown).
Effects of NO on NCX1, NCX2, and NCX3 Activity in BHK Cells Stably Transfected by Single-Cell Fura-2 Microfluorometry. The modulation exerted by NO on NCX1, NCX2, and NCX3 activity was studied in stably transfected BHK cells in the presence of the NO-donor SNAP or the NO precursor L-arginine by means of single-cell Fura-2 microfluorometry (Fig. 2) . NCX activity was evaluated in the reverse mode of operation by monitoring [Ca 2ϩ ] i increases, elicited by an Na ϩ -deficient NMDG ϩ (Na ϩ -free) medium, in the presence of the sarco(endo)plasmic reticulum Ca 2ϩ ATPase inhibitor thapsigargin (1 M). In BHK-NCX1 cells, the perfusion of Na ϩ -free was followed by an increase in [Ca 2ϩ ] i that was further increased by the NO donor SNAP (10 nM), thus displaying a significant enhancement of its activity in the reverse mode of operation (Fig. 2, A and B) . Likewise, L-arginine (10 mM) reproduced the same stimulatory effect on NCX1 reverse mode (Fig. 2, A and B) . The latter action was cGMP-independent because the guanylyl-cyclase inhibitor ODQ (100 nM) failed to prevent the NO-induced up-regulation of NCX1 activity (Fig. 2,  A ] i increases were significantly reinforced by SNAP (10 nM) (Fig. 2, C and D) . Likewise, preincubation with the NO precursor L-arginine (10 mM) was able to reproduce the same molpharm.aspetjournals.org stimulatory effect exerted by SNAP on NCX2 reverse mode of operation (Fig. 2, C and D) . However, unlike BHK-NCX1 cells, this increase was cGMP-dependent because the guanylyl-cyclase inhibitor ODQ (100 nM) not only reduced its basal activity but also prevented NO-induced increases in NCX2 activity operating in the reverse mode (Fig. 2D) . To confirm the role of cGMP in NO-mediated NCX2 stimulation, the effect of its cellpermeable analog 8-Br-cGMP (500 M) was studied in BHK-NCX2 cells. As expected, it reproduced the same stimulatory effect exerted by NO on Na ϩ -free-induced NCX2 activity (Fig.  2D) . Unlike the stimulatory effect of NO on the activity of NCX1 and NCX2, single-cell Fura-2 experiments revealed that the NO donor SNAP (10 nM) significantly reduced NCX3 reverse mode of operation (Fig. 2, E and F) . Likewise, preincubation with the NOS substrate L-arginine (10 mM) reproduced the same inhibitory effect (Fig. 2, E and F) . Furthermore, NO effect on NCX3 was cGMP-independent because the guanylyl-cyclase inhibitor ODQ (100 nM) failed to counteract this inhibition (Fig. 2F) .
Effects of NO on I NCX1 , I NCX2 , and I NCX3 Measured in Stably Transfected BHK Cells by Patch Clamp in Whole-Cell Configuration. To further characterize the differential roles exerted by NO on the activity of the NCX isoforms, patch-clamp recordings in whole-cell configuration were performed. Electrophysiological studies on BHK-NCX1 and BHK-NCX2 cells revealed that NO donor SNAP (10 nM) and L-arginine (10 nM) were able to enhance I NCX1 (Fig. 3, A and B) and I NCX2 (Fig. 3, C and D) either in the forward or reverse mode of operation. By contrast, experiments on BHK-NCX3 cells showed that both NO-donor SNAP (10 nM) and L-arginine (10 mM) inhibited I NCX3 in the reverse and forward modes of operation compared with control currents (Fig. 3, E and F) .
Effects of NO on the Activity NCX1, NCX2, and NCX3 Mutants and Chimeras in Stably Transfected BHK Cells. To investigate the molecular determinants of NO on the molecular structure of each NCX isoform, the intracellular f-loop, a region mainly involved in the regulation of NCX function, was deleted in NCX1, NCX2, and NCX3 cDNAs. In particular, the effect of the gaseous mediator was investigated in NCX1⌬241-680, NCX2⌬269-662, and NCX3⌬292-708 mutants lacking the f-loop and named NCX1,2,3⌬f (Fig. 4) . Fura-2/AM single-cell video-imaging and patchclamp experiments revealed that the elimination of the f-loop Fig. 3 . Effect of the NO donor SNAP and the NO precursor L-arginine on I NCX1 , I NCX2 , and I NCX3 evaluated both in the reverse and in the forward modes of operation by means of patch-clamp in stably transfected BHK cells. A, I NCX superimposed traces recorded from BHK-NCX1 cells under control conditions (black trace) and after 10 min preincubation with SNAP (10 nM) (gray trace). The electrophysiological protocol is reported at the top. B, I NCX1 quantification of the reverse mode at ϩ10 mV and of the forward mode at Ϫ120 mV under control conditions and after 10-min preincubation with either L-arginine (10 mM) or SNAP (10 nM). The values are expressed as mean Ϯ S.E.M. of current densities recorded from 20 cells in each experimental group obtained from three independent experimental sessions. ‫,ء‬ P Ͻ 0.05 versus each respective control. C, I NCX superimposed traces recorded from BHK-NCX2 cells under control conditions (black trace) and after 10-min preincubation with SNAP (10 nM) (gray trace). D, I NCX2 quantification of the reverse mode at ϩ60 mV and the forward mode at Ϫ120 mV under control conditions and after 10-min preincubation with L-arginine (10 mM) or SNAP (10 nM). The values are expressed as mean Ϯ S.E.M. of current densities recorded from 30 cells in each experimental group obtained from three independent experimental sessions. ‫,ء‬ P Ͻ 0.05 versus each respective control. E, I NCX superimposed traces recorded from BHK-NCX3 cells under control conditions (black trace) and after 10-min preincubation with SNAP (10 nM) (gray trace). F, I NCX3 quantification of the reverse mode at ϩ60 mV and of the forward mode at Ϫ120 mV under control conditions and after 10-min preincubation with L-arginine (10 mM) or SNAP (10 nM). The values are expressed as mean Ϯ S.E.M. of current densities recorded from 20 cells in each experimental group obtained from three independent experimental sessions. ‫,ء‬ P Ͻ 0.05 versus each respective control. produced a significant change in the action profile exerted by NO on NCX1 and NCX2 activity. In fact, the removal of the f-loop not only abolished the stimulatory effect of SNAP (10 nM) observed in NCX1 and NCX2 wild-type isoforms but also converted NO stimulation into an inhibition of NCX1⌬f and NCX2⌬f mutant activity, both in the reverse and in the forward modes of operation (Fig. 4, A, B , and C). L-Arginine (10 mM) reproduced the same effect exerted by the NO-donor on each cellular clone (data not shown).
In contrast, the removal of the f-loop did not prevent the inhibitory action of SNAP (10 nM) on NCX3 either in the reverse or in the forward mode of operation (Fig. 4, A, B , and C), suggesting the existence of an inhibitory site located outside this region. Moreover, to better characterize the portion of the NCX1 and NCX2 f-loop involved in NO stimulatory action, we generated two NCX1 mutants lacking the 246 to 321 (NCX1⌬246-321) and 723 to 734 (NCX1⌬723-734) segments, respectively. The deletion of the 246 to 321 sequence from the NCX1 f-loop did not prevent the boosting effect of the NO-donor on its activity, as recorded in the reverse mode of operation by patch-clamp and Fura-2 microfluorometry (Fig. 5, B and E). However, the NO donor did not affect the forward mode of operation of NCX1⌬246-321 (Fig.   5, B and E) . On the other hand, the deletion of the 723 to 734 sequence, a region with a lower percentage of identity with the sequence of the other two NCX isoforms (see alignment of Fig. 5 ) prevented the NO-stimulatory effect on NCX1 activity (Fig. 5, C and E) . Indeed, SNAP (10 nM) was able to inhibit rather than potentiate the activity of NCX1⌬723-734 both in the reverse and in the forward modes of operation, as recorded by patch-clamp and Fura-2 microfluorometry (Fig. 5,  C and E) . Moreover, the single substitution of the Cys730 with a serine within this portion in NCX1C730S mutant was sufficient to reproduce SNAP inhibitory effect observed in NCX1⌬723-734 (Fig. 5, D and E) . L-Arginine (10 mM) reproduced the same effect exerted by the NO-donor on each of these NCX1 mutants (data not shown).
Regarding NCX2, deletion mutagenesis revealed that the elimination of the f-loop portion 669 to 744 (NCX2⌬669-744) but not of the 275 to 348 region (NCX2⌬275-348) prevented the NO-mediated stimulatory effect (Fig. 6 , B, C, and E). In fact, SNAP (10 nM) inhibited rather than potentiated the activity of NCX2⌬669-744 mutant both in the reverse and in the forward modes of operation, as recorded by patch-clamp and Fura-2 microfluorometry (Fig. 6 , C and E). It is noteworthy that the substitution of the four amino acids DGSR in the 711-to-714 sequence of NCX2 with the two amino acids SG present in the corresponding NCX3 region was sufficient to prevent the NO-mediated stimulatory effect on NCX2 activity (Fig. 6, D and E) . Indeed, patch-clamp and Fura-2/AM data evidenced that SNAP (10 nM) inhibited rather than potentiated the activity of this mutant named NCX2SG (Fig.  6, D and E) . L-Arginine (10 mM) reproduced the same effect exerted by the NO-donor on each NCX2 mutant (data not shown).
To establish the site responsible for NO-mediated downregulation of NCX3 activity, we performed a site-directed mutagenesis of the Cys156 in the ␣1 repeat sequence, a site potentially involved in NO inhibitory modulation. Actually, the substitution of Cys156 with a serine (NCX3C156S) prevented the NO-mediated inhibition of NCX3 activity in the reverse and forward modes of operation, as revealed by patch-clamp and Fura-2 microfluorometry (Fig. 7, B and E).
These data were also reproduced by the NO-precursor L-arginine (10 mM) (data not shown).
To further support the data obtained by deletion and sitedirected mutagenesis on NO determinants present on each NCX isoform, we generated two chimeras between NCX3 and NCX1 or NCX3 and NCX2, respectively. In particular, we substituted the NO-insensitive NCX3 region 707 to 776 with the homologous NOsensitive NCX1 segment 718 to 787, thus producing the chimera named NCX3 (Fig. 7C) . It is noteworthy that the activity of this NCX3 NCX1TM6-floop chimera was potentiated by SNAP (10 nM) in both the reverse and the forward modes of operation, as recorded by patch-clamp and Fura-2 microfluorometry (Fig. 7, C and E) . Furthermore, a chimera between NCX3 and NCX2, named NCX3 NCX2DGSR ,was produced by introducing in the NO-insensitive NCX3 region 719 to 720 the homologous NO-sensitive NCX2 sequence 711 to 714 (Fig. 7D) . Patch-clamp and Fura-2 microfluorometry recordings showed that NCX3 NCX2DGSR chimera activity was enhanced by SNAP (10 nM) (Fig. 7, D and E) . L-Arginine (10 mM) reproduced the same effect exerted by the NO donor on each chimera (data not shown).
Discussion
The results of the present study demonstrated that the gaseous mediator NO up-regulates the activity of both NCX1 and NCX2 isoforms in a cGMP-independent and -dependent manner, respectively. By contrast, the gaseous mediator inhibits NCX3 activity in a cGMP-independent way. The molecular determinant of NO action on NCX1 was localized within the f-loop at the level of Cys730, whereas that of NCX2 was localized within the corresponding region of the same loop at the level of 711 to 714. It is noteworthy that the molecular determinant of NCX3 was found outside the f-loop at the level of the ␣1 repeat.
Regarding cGMP-independent stimulatory action of NO on NCX1, it should be emphasized that the molecular determinant was a cysteine, thus suggesting that NO might increase NCX1 activity by direct nitrosylation occurring in the f-loop (i.e., the main regulatory domain of this antiporter). Instead, the molecular determinant of the cGMP-dependent NO action on NCX2 was a segment containing a serine, an amino acid that in several proteins is phosphorylated by cGMP-dependent kinases (PKG) (Francis et al., 2010) . It is noteworthy that the putative NCX2 phosphorylation site DGSR, found in the present study, displays some similarities with the canonic consensus sequence of PKG (R/K -2-3 )(X/K)(S/T)X (Glass and Krebs, 1982) but differs only for the amino acid position in P Ϫ2 (R/K -2-3 ). However, it has been reported that although this amino acid is apparently not crucial for the phosphorylation of PKG, it does improve its affinity for the substrate. On the other hand, it cannot be excluded that PKG might Another peculiar aspect of NCX2 modulation was that in the absence of cGMP stimulation by the NO donor, inhibition of the guanylyl cyclase by ODQ reduced Na ϩ -free-evoked NCX2 activity, suggesting that basal levels of cGMP may also participate in the regulation of NCX2 activity. On the other hand, when ODQ is coincubated with L-arginine, the reduction in NCX2 activity does not reach the same level as that observed with ODQ alone. However, when ODQ exerts its inhibitory action on guanylyl-cyclase activity in the absence of L-arginine, cGMP levels are probably lower than those occurring in the presence of L-arginine. On the other hand, the possibility that L-arginine could exert a stimulatory effect on NCX2 through a cGMP-independent mechanism can not be ruled out.
Regarding cGMP-independent inhibition of NO on NCX3, all NCX mutants lacking the f loop (NCX1⌬f, NCX2⌬f, and NCX3⌬f) were affected in the same way. This suggested that the putative nitrosylation site is located outside of this regulatory domain and is highly conserved among the NCX isoforms (Ottolia et al., 2005) . It is noteworthy that the mutation of the highly conserved Cys156, located at the level of the ␣ 1 repeat, prevented the NO-mediated inhibition of NCX3. Likewise, we could hypothesize that the homologous cysteine present in NCX1 and NCX2 may represent the molecular determinant of NCX1⌬f and NCX2⌬f inhibition by NO.
In addition, the participation of NO in the stimulation of NCX1 and NCX2 sequences 718 to 787 and 711 to 714, respectively, was further highlighted by NCX1/NCX2/NCX3 chimeras. In particular, when NCX3 chimeras were generated by replacing the NO-insensitive region with the homologous NO-sensitive segments of NCX1 or NCX2, the inhibitory action of NO on NCX3 activity was converted into a stimulatory one. Another intriguing finding emerging from the NCX1 and NCX2 mutants lacking the f-loop was that these two isoforms, in addition to having stimulatory molecular determinants, were also provided with a second site outside of the hydrophilic f-loop that mediated an NO-inhibitory action. However, despite the presence of this outer site, the effect of NO on the stimulatory sites prevailed. Although a definitive explanation for the role of this inhibitory site is still lacking, we could advance the hypothesis that the presence of this molecular determinant might become prevalent when changes in transductional factors-elicited by some pathophysiological conditions-turn off the stimulatory site. In previous studies, Asano et al. (1995) reported that cGMP and NO donors enhanced NCX activity in cultured rat astrocytes and cortical brain slices. However, they were unable to characterize the single contribution of each NCX isoform to this stimulatory action. This was probably because of the fact that when the three NCX isoforms are coexpressed in the same cells, the inhibitory effect of NO on NCX3 might be masked by the stimulatory action of the gaseous mediator on NCX1 and NCX2 isoforms.
In this regard, our study has provided several meaningful and insightful findings on the effect of NO on the modulation of the three NCX isoforms. First, NO can either stimulate or inhibit NCX isoforms. Second, it can selectively modulate each NCX isoform by acting on different molecular determinants that are specific for each isoform. Finally, it can exert its effect through different biochemical mechanisms. More specifically, the close interaction between NO and the three isoforms might indeed have biological relevance, because it occurs with several other intracellular factors including reactive oxygen species, [ Annunziato et al., 2004) . For instance, NO production does undergo critical changes under physiological or pathophysiological conditions such as anoxia, oxidative stress, and neurodegenerative diseases (Annunziato et al., 2002) in which each NCX isoform plays a specific role (Boscia et al., 2006; Secondo et al., 2007; Sirabella et al., 2009 ).
Together, this study indicates that the gaseous mediator NO differently regulates NCX1, NCX2, and NCX3 activity. In particular, it stimulates NCX1 and NCX2 activity in cGMPindependent and cGMP-dependent manner, respectively. In addition, the molecular determinants of NO on NCX1 and NCX2 are localized in the same regulatory region of the f-loop, although it is differently modulated. In contrast, NO inhibits NCX3 activity, and, unlike the other sites, its molecular determinant is localized outside of the f-loop, at the level of the ␣1 repeat.
